Randomized phase 3 study evaluating the efficacy and safety of nivolumab vs bevacizumab in patients with recurrent glioblastoma: CheckMate 143 Meeting Abstract
| Authors: | Reardona, D. A.; Omuroa, A.; Brandes, A. A.; Rieger, J.; Wick, A.; Sepulveda, J.; Phuphanich, S.; de Souza, P.; Ahluwalia, M. S.; Lim, M.; Vlahovicb, G.; Sampsonb, J. |
| Abstract Title: | Randomized phase 3 study evaluating the efficacy and safety of nivolumab vs bevacizumab in patients with recurrent glioblastoma: CheckMate 143 |
| Meeting Title: | 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS) |
| Journal Title: | Neuro-Oncology |
| Volume: | 19 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2017 May 4-7 |
| Meeting Location: | Zurich, Switzerland |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-05-01 |
| Start Page: | iii21 |
| Language: | English |
| ACCESSION: | WOS:000402732900073 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/nox036.071 |
| PMCID: | PMC5463583 |
| Notes: | Meeting Abstract: OS10.3 -- Source: Wos |
